Evidence map›Paper›PMID 29789369›Full record

ArticlemBio2018

M J Schultz, A L Tan, C N Gray, S Isern, S F Michael, H M Frydman, J H Connor

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Pan-Genome Analysis ofInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Pathogens and global health · 2023
    Article
  12. Review
  13. UsingFrontiers in microbiology · 2023
    Review
  14. PNAS nexus · 2022
    Article
  15. Article
  16. Article
  17. Two Newly IntroducedApplied and environmental microbiology · 2021
    Article
  18. mBio · 2021
    Article
  19. UsingJournal of virology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M J SchultzDepartment of Biology, Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-5054-8029
A L TanDepartment of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
C N GrayDepartment of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
S IsernDepartment of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
S F MichaelDepartment of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
H M FrydmanDepartment of Biology, Boston University, Boston, Massachusetts, USA.ORCID 0000-0003-0191-7948
J H ConnorNational Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA jhconnor@bu.edu.ORCID 0000-0002-8867-7256
Florida Gulf Coast University · USBoston University · US

Funding

Design of a human monoclonal antibody-informed dengue vaccineR01AI099210 · NIAID · FLORIDA GULF COAST UNIVERSITY · PI ISERN, SHARON · 2013 to 2016
$1.7M
Genetic probing of residues involved in ebolavirus glycoprotein entryR21AI135517 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CONNOR, JOHN H · 2018 to 2019
$454k
Assessment of infection route and vulnerability of neural precursor classes to Zika virusR21NS101151 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CONNOR, JOHN H, HAYDAR, TARIK F · 2016 to 2017
$452k
Role for polyamines in Ebola Virus ReplicationR21AI121933 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CONNOR, JOHN H · 2016 to 2017
$452k
Manipulation of stem cell activity and cell death by intracellular bacteriaR56AI097589 · NIAID · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI FRYDMAN, HORACIO M · 2013 to 2013
$385k
NIAID NIH HHS R01 AI099210NIAID NIH HHS R21 AI121933NIAID NIH HHS R21 AI135517NIAID NIH HHS R56 AI097589NINDS NIH HHS R21 NS101151
6 · The paper itself

Abstract

Mosquito-transmitted viruses are spread globally and present a great risk to human health. Among the many approaches investigated to limit the diseases caused by these viruses are attempts to make mosquitos resistant to virus infection. Coinfection of mosquitos with the bacterium

Indexed as

AntibiosisVirus ReplicationAedesAnimalsChikungunya virusDengue VirusMaleMosquito VectorsVirus InternalizationWolbachiaZika Virusarbovirusarthropod vectorsbiocontrolmechanisms of actionWolbachia

Identifiers

PMID29789369
PMCPMC5964347
OpenAlexW2803712251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.